Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Krill oil may help reduce prostate enlargement and growth.

Ritlecitinib can help about 14,000 people with severe hair loss.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Certain gene mutations in Japanese people are linked to different types of hair loss, with some causing mild hair thinning and others leading to complete baldness.

A 5-year-old girl had liver damage twice after using the herbal product Shou-Wu-Pian.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Most injecting drug users in the study had hepatitis C and skin problems, which moderately affected their quality of life.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

LIPH mutations in Japan cause varying degrees of hair loss and woolly hair.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.